REFERENCES
- Beretta S., Sala G., Matavelli L., Ceresa C., Casciati A., Ferri A., Carri M. T., Ferrarese C. Mitochondrial dysfunction due to mutant copper/Zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-actylcysteine. Neurobiology of Disease 2003; 13: 213–221, [PUBMED], [INFOTRIEVE], [CSA]
- Finsterer J. Mitochondriopathy as a differential diagnosis of amyotrophic lateral sclerosis. . Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002; 3: 219–224, [PUBMED], [INFOTRIEVE], [CSA]
- Finsterer J. Reproducibility of the lactate stress test. Metabolic Brain Disease 2003; 18: 155–161, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Finsterer J., Milvay E. Lactate stress testing in 155 patients with respiratory chain disorders. Canadian Journal of Neurological Sciences 2002; 29: 49–53, [PUBMED], [INFOTRIEVE], [CSA]
- Finsterer J., Milvay E. Stress lactate in mitochondrial myopathy under constant, unadjusted workload. European Journal of Neurology 2004; 11: 811–816, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Finsterer J., Obermann I., Milvay E. Diagnostic yield of the lactate stress test in 160 patients with suspected respiratory chain disorder. Metabolic Brain Disease 2000; 15: 163–171, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jeppesen T. D., Olsen D., Vissing J. Cycle ergometry is not a sensitive diagnostic test for mitochondrial myopathy. Journal of Neurology 2003; 250: 293–299, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Menzies F. M., Cookson M. R., Taylor R. W., Turnbull D. M., Chrzanowska Lightowlers. Z., Dong L., Figlewicz D. A., Shaw P. J. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 2002; 125: 1522–1533, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Morgan-Hughes J. A. The mitochondrial myopathies. Myology: Basic and clinical, A. G. Engel, C. Franzini-Armstrong. McGraw-Hill, New York 1994; pp. 1610–1651
- Morrison K. E. Therapies in amyotrophic lateral sclerosis beyond riluzole. Current Opinion in Pharmacology 2002; 2: 302–309, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Norris F. H., Calanchini P. R., Fallat R. J., Panchari S., Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974; 24: 721–728, [PUBMED], [INFOTRIEVE]
- Siciliano G., Pastorini E., Pasquali L., Nanca M. L., Iudica A., Murri L. Impaired oxidative metabolism in exercising muscle of ALS patients. Journal of the Neurological Sciences 2001; 191: 61–65, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Siciliano G., Murri L. A screening for superoxide dismutase-1 D90A mutation in Italian patients with sporadic amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002; 3: 215–218, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Siciliano G., D'Avino C., Del Corona A., Barsacchi R., Kusmic C., Rocchi A., Pastorini E., Murri L. Impaired oxidative metabolism and lipid peroxi-dation in exercising muscle from ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002; 3: 57–62, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Strong M., Rosenfeld J. Amyotrophic lateral sclerosis: A review of current concepts. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2003; 4: 136–143, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sugawara T., Lewen A., Gasche Y., Yu F., Chan P. H. Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB Journal 2002; 16: 1997–1999, [PUBMED], [INFOTRIEVE]
- World federation of neurology research group on neuromuscular diseases. Subcommittee on motor neurone diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the El Escorial "clinical limits of amyotrophic lateral sclerosis" workshop contributors. El Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Journal of Neurological Science 1974; 124: 96–107